Introduction: A New Chapter in Public Health Diplomacy
In a landmark development for international health governance, the World Health Organization (WHO) and the Swiss Confederation have officially renewed their Cooperation Strategy for the 2024–2028 period. This formal agreement, finalized on March 4, 2025, at the WHO Regional Office for Europe in Copenhagen, Denmark, marks a deepening of a unique partnership that has served as a global benchmark for collaboration between a multilateral health agency and a high-income member state.
The strategy, signed by Dr. Hans Henri P. Kluge, WHO Regional Director for Europe, and Barbara Schedler, Ambassador for Global Health at the Swiss Federal Office of Public Health (FOPH), represents more than just a bureaucratic renewal. It is a strategic alignment of resources, policy frameworks, and technical expertise designed to address the increasingly complex challenges of a post-pandemic world. As global health systems face the dual pressures of climate change, aging populations, and the constant threat of emerging pathogens, this bilateral cooperation serves as a vital pillar for regional and global stability.
Chronology: A Decade of Collaborative Evolution
To understand the significance of the 2024–2028 agreement, one must look back at the developmental trajectory of the WHO-Switzerland relationship.
2013: The Pilot Phase
In 2013, Switzerland broke new ground by becoming the first high-income country within the WHO European Region to initiate a formal "Country Cooperation Strategy" (CCS). Historically, the CCS instrument was designed primarily for low- and middle-income nations to help prioritize WHO technical support. Switzerland’s decision to pilot this model recognized that even wealthy nations benefit from structured, strategic alignment with international health norms.
2022: The Decision to Renew
Following a decade of successful implementation, both parties recognized that the rapidly shifting landscape of global health—marked significantly by the COVID-19 pandemic—required a modernization of their strategic framework. In 2022, officials from the Swiss FOPH and the WHO European Office began the consultative process to draft a new roadmap that would better reflect current geopolitical realities and public health priorities.
2025: Formalization
The culmination of these efforts occurred on March 4, 2025. By cementing the cooperation through 2028, both parties have ensured a stable planning horizon for joint initiatives, including health security, digital health integration, and workforce development.
The Strategic Framework: Core Pillars of the 2024–2028 Agreement
The new cooperation strategy is not a static document; it is a dynamic plan centered on several key thematic areas that define modern public health excellence.
1. Strengthening Global Health Security
Building on the lessons of the COVID-19 pandemic, the agreement prioritizes the refinement of health security architectures. This involves not only pandemic preparedness but also the strengthening of national surveillance systems capable of detecting cross-border health threats in real-time.
2. The Global BioHub System
A central element of this partnership is the continued development of the WHO BioHub system. Based in Switzerland, this initiative facilitates the voluntary sharing of biological materials (pathogens) between countries. This system is critical for the rapid development of medical countermeasures, including vaccines, diagnostics, and therapeutics. By providing a safe, secure, and transparent framework for pathogen sharing, the BioHub exemplifies the tangible impact of the Swiss-WHO synergy.
3. Digital Health and Innovation
Switzerland’s robust technological sector provides an ideal testing ground for WHO’s digital health initiatives. The strategy emphasizes the integration of AI, telemedicine, and secure data exchange protocols to improve healthcare delivery efficiency, particularly for vulnerable populations and those living in remote or rural areas.
4. Health Equity and Non-Communicable Diseases (NCDs)
While Switzerland enjoys high standards of health, the agreement addresses internal disparities and the rising burden of NCDs such as cardiovascular disease, diabetes, and mental health disorders. The strategy outlines a collaborative approach to preventive health, focusing on lifestyle modifications and the integration of social determinants of health into clinical practice.
Supporting Data: Why the Partnership Matters
The efficacy of the WHO-Switzerland cooperation is supported by the unique position of both entities. Switzerland serves as a major hub for global health governance, hosting not only the WHO headquarters in Geneva but also numerous international organizations, research institutes, and private sector pharmaceutical giants.
- Financial and Technical Contributions: Switzerland remains one of the largest voluntary contributors to the WHO’s core budget. Beyond financial support, the Swiss "in-kind" contribution—providing world-class laboratory facilities and specialized technical expertise—is arguably more significant.
- The "Swiss Model" of Cooperation: By utilizing a CCS, Switzerland allows WHO to gain deeper insights into the health policies of advanced economies. This creates a feedback loop where Switzerland adopts WHO global best practices, and the WHO uses Swiss data to refine models for other high-income nations.
- Impact Metrics: Since the inception of the strategy in 2013, the collaboration has been instrumental in drafting national policies on antimicrobial resistance (AMR), health system sustainability, and the digitalization of public health records, all of which have seen measurable improvements in national health outcomes.
Official Perspectives: Aligning Visions
During the signing ceremony in Copenhagen, both leaders emphasized the necessity of a forward-looking partnership.
The WHO Perspective
Dr. Hans Henri P. Kluge noted that the partnership serves as a beacon for other developed nations. "The renewal of this strategy is a testament to the fact that international cooperation is not merely a mechanism for development aid, but a vital necessity for shared security," Dr. Kluge stated. He highlighted that Switzerland’s commitment to the WHO goes beyond funding, representing an intellectual and operational commitment to global health equity.
The Swiss Perspective
Ambassador Barbara Schedler emphasized that Switzerland’s commitment to global health is an extension of its national policy of neutrality and humanitarian tradition. "By aligning our national strategy with the broader WHO European agenda, we are ensuring that Switzerland remains at the forefront of the global fight against health threats while simultaneously strengthening our own internal healthcare resilience," Schedler noted.
Global Implications: A Model for Multilateralism
The renewal of the WHO-Switzerland cooperation comes at a time when multilateralism is under pressure globally. Critics of international organizations often cite a lack of agility and disconnect from national realities. However, this bilateral strategy offers a potent rebuttal to those claims.
Influence on the WHO European Region
The 2024–2028 strategy acts as a template for other European nations. By demonstrating how a high-income country can integrate its national priorities with regional health goals, the WHO is encouraging a more cohesive "European Health Union" approach. This is particularly relevant in the context of the European Program of Work (EPW), which prioritizes universal health coverage, protection against health emergencies, and healthier lives.
Implications for Global Health Security
The BioHub initiative, specifically, has far-reaching implications for the Global South. By ensuring that research findings and biological data are treated as "global public goods," the partnership between Switzerland and the WHO helps bridge the gap between innovation in the North and access in the South. The strategy reinforces the principle that health security is indivisible; a pathogen emerging in any part of the world poses a risk to all, and therefore, the infrastructure for detection must be global.
Challenges and Future Outlook
Despite the optimistic outlook, the 2024–2028 period will not be without challenges. The integration of artificial intelligence in public health raises complex ethical and data-privacy questions. Furthermore, as the world navigates the transition toward sustainable health systems, balancing innovation costs with universal access remains a difficult policy needle to thread.
However, the structural design of the renewed strategy—which includes biennial reviews—allows for the flexibility needed to pivot in response to these emerging challenges. Whether it is the integration of new genomic surveillance technologies or the adaptation of healthcare systems to climate-induced health crises, the cooperation framework is designed to evolve.
Conclusion: A Partnership for the Future
The renewal of the WHO-Switzerland Cooperation Strategy for 2024–2028 is a milestone that transcends simple diplomatic protocol. It is a strategic commitment to the idea that science, policy, and cooperation are the most effective tools in the arsenal of human progress. As Switzerland and the WHO embark on this next chapter, the world watches with interest, as the successes of this partnership will undoubtedly shape the standards of public health governance for years to come.
Through this agreement, both parties are sending a clear message: in an era of global uncertainty, the most reliable path forward is one built on structured, evidence-based, and deeply collaborative partnerships. The work that begins in the labs of the BioHub and the policy offices of the FOPH will, ultimately, manifest in safer, healthier lives for citizens across the globe.
About the Author
